IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

FDA Seizes Contaminated Heparin from Celsus Laboratories

9:32 AM MST | November 18, 2008 | Deepti Ramesh

U.S. Marshals on the FDA’s request have seized 11 lots of contaminated blood-thinning drug heparin from pharmaceutical manufacturer Celsus Laboratories (Cincinnati), FDA says. The seized drugs include five lots of heparin sodium active pharma ingredients (API) and six lots of heparin lithium, FDA says. The products were found to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin’s anticoagulant activity, the agency says. The products were made with raw materials imported from China, it adds. The agency has...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.


Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis from the entire global chemical enterprise on chemweek.com
  • Mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa